This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: George Mason University, The University of Arizona. Active years: 2026.
Company Filing History:
1 out of 270 
1 out of 1,053 Years Active: 2026
Title: The Innovative Contributions of Sally E Dickinson
Introduction
Sally E Dickinson is a notable inventor based in Tucson, Arizona. She has made significant contributions to the field of medical research, particularly in the area of skin cancer prevention. Her innovative work focuses on the PD-1/PD-L1 signaling pathway, which plays a crucial role in determining the risk of skin cancer development.
Latest Patents
Sally E Dickinson holds a patent for a method of determining risk for skin cancer development and therapeutic prevention by measuring members of the PD-1/PD-L1 signaling pathway. This invention allows for quantitative measurements of UV-induced expression of PD-1, PD-L1, and PD-L2, as well as regulatory factors like AP-1 and NFκB in skin tissue. The method aims to identify individuals at risk for pre-malignant skin lesions and non-melanoma skin cancer, facilitating appropriate prophylactic treatment strategies.
Career Highlights
Throughout her career, Sally has worked with esteemed institutions such as the University of Arizona and George Mason University. Her research has contributed to a better understanding of skin cancer and the development of preventive measures.
Collaborations
Sally E Dickinson has collaborated with Amanda Fern Baker, who has also contributed to her research endeavors.
Conclusion
Sally E Dickinson's innovative work in skin cancer research exemplifies the importance of scientific advancements in healthcare. Her contributions continue to pave the way for improved preventive strategies against skin cancer.